Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice. 2013

Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
1 Department of Respiratory Medicine and Rheumatology and.

Focal adhesion kinase (FAK) is a nonreceptor tyrosine kinase involved in various biological functions, including cell survival, proliferation, migration, and adhesion. FAK is an essential factor for transforming growth factor β to induce myofibroblast differentiation. In the present study, we investigated whether the targeted inhibition of FAK by using a specific inhibitor, TAE226, has the potential to regulate pulmonary fibrosis. TAE226 showed inhibitory activity of autophosphorylation of FAK at tyrosine 397 in lung fibroblasts. The addition of TAE226 inhibited the proliferation of lung fibroblasts in response to various growth factors, including platelet-derived growth factor and insulin-like growth factor I, in vitro. TAE226 strongly suppressed the production of type I collagen by lung fibroblasts. Furthermore, treatment of fibroblasts with TAE226 reduced the expression of α-smooth muscle actin induced by transforming growth factor β, indicating the inhibition of differentiation of fibroblasts to myofibroblasts. Administration of TAE226 ameliorated the pulmonary fibrosis induced by bleomycin in mice even when used late in the treatment. The number of proliferating mesenchymal cells was reduced in the lungs of TAE226-treated mice. These data suggest that FAK signal plays a significant role in the progression of pulmonary fibrosis and that it can become a promising target for therapeutic approaches to pulmonary fibrosis.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell

Related Publications

Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
March 2023, BMC pulmonary medicine,
Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
January 2022, Frontiers in pharmacology,
Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
January 2019, Frontiers in pharmacology,
Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
January 2012, International journal of molecular sciences,
Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
August 2016, The Tohoku journal of experimental medicine,
Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
May 2006, American journal of respiratory and critical care medicine,
Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
July 1997, American journal of respiratory and critical care medicine,
Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
June 2005, American journal of respiratory and critical care medicine,
Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
July 2022, International journal of molecular sciences,
Katsuhiro Kinoshita, and Yoshinori Aono, and Momoyo Azuma, and Jun Kishi, and Akio Takezaki, and Masami Kishi, and Hideki Makino, and Hiroyasu Okazaki, and Hisanori Uehara, and Keisuke Izumi, and Saburo Sone, and Yasuhiko Nishioka
December 2021, International journal of molecular sciences,
Copied contents to your clipboard!